연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2687. High Circulating Levels of Neutrophil Extracellular Traps Parameters Predicting Poor Outcome in COVID-19
Seunghwan Kim 1, Ki Ho Hong 2, Ja-Yoon Gu 1 3, Ji Won In 4, Mi Young Ahn 5, Hyun Kyung Kim 6 3
Ann Clin Lab Sci. 2022 May;52(3):374-381.
Link
2686. Prognostic value of the ADAMTS13-vWF axis in disseminated intravascular coagulation: Platelet count/vWF:Ag ratio as a strong prognostic marker
Joowon Jang 1, JaYoon Gu 1 2, Hyun Kyung Kim 1 2
Int J Lab Hematol. 2022 Jun;44(3):595-602
Link
2685. Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors
Sooyong Park 1, Ja-Yoon Gu 1 2, Hyun Kyung Kim 3 4
J Thromb Thrombolysis. 2022 Jul;54(1):11-14.
Link
2684. Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Lee TH, Kim HJ, Kim BH, Kang CH, Keam B, Moon HJ, Seong YW, Kim S
J Oncol. 2022 Jun 3;2022:5635071
Link
2683. Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
Kim BH, Chung JH, Son J, Kim S, Wu HG, Kim HJ
Cancer Res Treat. 2022 Mar 14. doi: 10.4143/crt.2021.1202. Online ahead of print
Link
2682. Survival impact of prophylactic cranial irradiation in small-cell lung cancer in the modern era of magnetic resonance imaging staging
Lim YJ, Song C, Kim HJ; Korean Association for Lung Cancer; Korea Central Cancer Registry
Radiat Oncol. 2022 Feb 5;17(1):26
Link
2681. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer
Young-Won Cho 1 2, Dong-Wook Min 1 2, Hwang-Phill Kim 1 2, Yohan An 3, Sheehyun Kim 4 5, Jeonghwan Youk 6, Jaeyoung Chun 7 8, Jong Pil Im 7, Sang-Hyun Song 2, Young Seok Ju 3 6, Sae-Won Han 4, Kyu Joo Park 9, Tae-You Kim 1 2 4
Mol Oncol. 2022 Jun;16(12):2396-2412.
Link
2680. EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer
Ye-Lim Park # 1 2, Hwang-Phill Kim # 3 4 5, Chan-Young Ock 6, Dong-Wook Min 4, Jun Kyu Kang 3 4, Yoo Joo Lim 6, Sang-Hyun Song 4, Sae-Won Han 4 6, Tae-You Kim 7 8 9
Oncogene. 2022 Apr;41(14):2026-2038
Link
2679. Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer
Yeongun Lee 1, So Hee Dho 1, Jiyeon Lee 1, Ji-Hyun Hwang 2, Minjung Kim 2, Won-Young Choi 2, Jin-Young Lee 3, Jongwon Lee 4, Woochul Chang 5, Min Young Lee 6, Jungmin Choi 4, Tae-You Kim 7, Lark Kyun Kim 8
Exp Mol Med. 2022 Feb;54(2):156-168.
Link
2678. Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study
Burhan Ferhanoglu 1, Tae Min Kim 2, Amado Karduss 3, David Brittain 4, Gayane Tumyan 5, Mubarak Al-Mansour 6 7, Marta Zerga 8, Yuqin Song 9, Silvia Rivas-Vera 10, Yok Lam Kwong 11 12, Soon Thye Lim 13, Su-Peng Yeh 14, Arif Abdillah 15, Zhongwen Huang 16, Mehul Dalal 16, Hui Wan 15, Mark Hertzberg 17 18
Leuk Lymphoma. 2022 Dec;63(14):3317-3330.
Link